White Paper

Traditional age-based mammography screening has been shown to reduce breast cancer mortality by approximately 20%, but screening mammography can still miss 20 to 40% of breast cancers. A risk-based screening approach for the detection of breast cancer is the next evolution for precision medicine in breast cancer care.

In partnership with researchers from the Karolinska Institute in Sweden, iCAD has developed ProFound AI Risk for use with both Full Field Digital Mammography (FFDM) and Digital Breast Tomosynthesis (DBT) mammography systems. ProFound AI Risk is the world’s first clinical decision support tool that provides an accurate short-term breast cancer risk estimation that is truly personalized for each woman, based only on her mammogram.

Download the whitepaper to learn how ProFound AI offers superior performance and unprecedented insights in assessing short-term risk compared to traditional, commonly-used breast cancer risk models.

Fill out form to download the whitepaper.

Please register for access to the webinar.

Lorem ipsum dolor sit amet

Ut Enim Minima

Sed ut perspiciatis unde omnis iste natus error sit voluptatem!

Quis Autem Vel

Nemo enim ipsam voluptatem quia voluptas sit odit aut fugit!

Quo Voluptas

Ut enim ad minima veniam, quis nostrum exercitationem ullam!